ANDE The Andersons, Inc.
The Andersons, Inc. operates as an agriculture and renewable fuels company in the United States, Canada, Mexico, and internationally. It operates through Agribusiness and Renewables segments. The Agribusiness segment sells commodities, such as corn, wheat, and soybeans. It also manufactures, distributes, and retails agricultural and related plant nutrients; and agricultural fertilizers. This segment also engages in the merchandising business, as well as offers logistics for physical commodities, such as whole grains, grain products, feed ingredients, domestic fuel products, and other agricultural commodities. The Renewables segment produces, purchases, sells, merchandises, and trades in ethanol, and co-products, as well as merchandises and trades in other biofuels, such as renewable feedstocks. The Andersons, Inc. was founded in 1947 and is based in Maumee, Ohio.…
Industry Peers
Food DistributionKey Statistics
About The Andersons (NASDAQ: ANDE)
›
The Andersons (NASDAQ: ANDE) is listed on Nasdaq, where its shares trade in USD. It belongs to the Food Distribution industry, part of the Consumer Defensive sector, and reports about 2,028 employees.
The shares were at 47.46 USD on 19 November 2026, down 2.4% over 52 weeks. Its 52-week range is 46.00 USD to 82.11 USD: the price is 42.2% below the high and 3.2% above the low.
At a market capitalisation of 1.60B USD, it trades at 8.0 times trailing earnings and 7.4 times forward earnings. The median trailing P/E of its 17 largest Food Distribution peers is 16.1, a discount of 50% for ANDE. It pays a dividend yielding 1.68% (it pays out 13% of its earnings), against a median of 4.42% among the dividend payers in that peer group.
The Andersons reports return on equity of 7.7%, an operating margin of 1.9% and revenue up 5.8% year over year.
Its debt exceeds its cash by 1.03B USD, a debt-to-equity ratio of 0.76. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 3 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 90.00 USD is 89.6% above the current price. The next earnings report is expected on 16 February 2027.